Pathogens pose massive health and economic risks. These and other Infectious diseases emerge or reemerge on a regular basis, threatening populations around the world from our densely populated urban centers to the most rural locations.
The constant threat posed by these pathogens drives demand for effective, safe and affordable vaccines. Unfortunately, the complexity and variety of vaccine types and manufacturing methods have prevented establishment of robust processing templates, which can leave vaccine manufacturers on their own to develop customized approaches for each pathogen and each outbreak.
At MilliporeSigma, our mission is to “solve the toughest problems in life science”. One of these problems is the need for more efficient and cost-effective manufacture of vaccines. To this end, we actively collaborate with academia, vaccine researchers and manufacturers with deep knowledge of their vaccine candidate and clinical aspects to develop and optimize innovative tools, processes and strategies to resolve bottlenecks and accelerate the availability of desperately needed vaccines.
In the following pages, you will find a series of case studies highlighting our recent collaborations with organizations and thought leaders on the front lines of the battle against these challenging pathogens. I know you will be inspired by these initiatives and I encourage you to contact us to explore new ways to tackle this problem, together.